Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 86

1.

Sequential use of opioid antagonists and agonists in Tourette's syndrome.

McConville BJ, Norman AB, Fogelson MH, Erenberg G.

Lancet. 1994 Mar 5;343(8897):601. No abstract available.

PMID:
7906352
2.

Naltrexone and Tourette's syndrome.

Erenberg G, Lederman RJ.

Ann Neurol. 1992 May;31(5):574. No abstract available.

PMID:
1596095
3.

A controlled trial of propoxyphene and naltrexone in patients with Tourette's syndrome.

Kurlan R, Majumdar L, Deeley C, Mudholkar GS, Plumb S, Como PG.

Ann Neurol. 1991 Jul;30(1):19-23.

PMID:
1681781
4.

Sequential use of opioid antagonists and agonists in Tourette's syndrome.

Chappell PB.

Lancet. 1994 Mar 5;343(8897):556. No abstract available.

PMID:
7906324
5.

Self-mutilation in Tourette's syndrome.

Sandyk R.

J Child Neurol. 1988 Apr;3(2):147-8. No abstract available.

PMID:
3163711
6.

Gilles de la Tourette's syndrome associated with chronic schizophrenia.

Sandyk R, Bamford CR.

Int J Neurosci. 1988 Jul;41(1-2):83-6.

PMID:
3165970
7.

Guanfacine for Tourette's disorder.

Fras I.

J Am Acad Child Adolesc Psychiatry. 1996 Jan;35(1):3-4. No abstract available.

PMID:
8567607
8.

Pharmacokinetics of pimozide in adults and children with Tourette's syndrome.

Sallee FR, Pollock BG, Stiller RL, Stull S, Everett G, Perel JM.

J Clin Pharmacol. 1987 Oct;27(10):776-81.

PMID:
3480904
9.

Methadone treatment of Tourette's disorder.

Meuldijk R, Colon EJ.

Am J Psychiatry. 1992 Jan;149(1):139-40. No abstract available.

PMID:
1728167
10.

Tourette's syndrome and treatment with clomipramine hydrochloride.

Donahoe DH, Meador M, Fortune T, Llorena R.

W V Med J. 1991 Oct;87(10):468-70.

PMID:
1767522
11.

Ketanserin treatment of Tourette's syndrome in children.

Bonnier C, Nassogne MC, Evrard P.

Am J Psychiatry. 1999 Jul;156(7):1122-3. No abstract available.

PMID:
10401479
12.
13.

Paroxetine treatment of episodic rages associated with Tourette's disorder.

Bruun RD, Budman CL.

J Clin Psychiatry. 1998 Nov;59(11):581-4.

PMID:
9862603
14.

Patterns of response to acute naloxone infusion in Tourette's syndrome.

van Wattum PJ, Chappell PB, Zelterman D, Scahill LD, Leckman JF.

Mov Disord. 2000 Nov;15(6):1252-4.

PMID:
11104215
15.

Serotonin-dopamine antagonist and Gilles de la Tourette's syndrome: an open pilot dose-titration study with risperidone.

van der Linden C, Bruggeman R, van Woerkom TC.

Mov Disord. 1994 Nov;9(6):687-8. No abstract available.

PMID:
7531282
16.

Naltrexone suppresses abnormal sexual behavior in Tourette's syndrome.

Sandyk R.

Int J Neurosci. 1988 Nov;43(1-2):107-10.

PMID:
3215726
17.

Conflicting and inconsistent dosing advice for clonidine in Tourette's syndrome.

Holmes TS.

J Clin Psychiatry. 1998 Nov;59(11):620. No abstract available.

PMID:
9862608
18.

Tardive or atypical Tourette's disorder in a population with Down syndrome?

Myers B, Pueschel SM.

Res Dev Disabil. 1995 Jan-Feb;16(1):1-9.

PMID:
7701088
19.

Gilles de la Tourette's syndrome: biochemical approaches.

Van Woert MH, Jutkowitz R, Rosenbaum D, Bowers MB Jr.

Res Publ Assoc Res Nerv Ment Dis. 1976;55:459-65.

PMID:
1070064
20.

Citalopram and fluvoxamine in Tourette's disorder.

Bajo S, Battaglia M, Pegna C, Bellodi L.

J Am Acad Child Adolesc Psychiatry. 1999 Mar;38(3):230-1. No abstract available.

PMID:
10087681
Items per page

Supplemental Content

Support Center